ATM Variants in Radiotherapy Patients

Status Completed

Clinical Trial Summary

The purpose of this study is to compare the baseline incidence of variant alleles in the ATM and/or other DNA repair genes present in the Native American population versus the non-Native American population. It is thought that a higher baseline incidence of the variant alleles in the ATM gene may correlate to higher rates and higher grades of radiation toxicities noted in the Native American population.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Radiotherapy

Clinical Trial Details

NCT number	NCT00214227
Study type	Observational
Source	University of Wisconsin, Madison
Contact
Status	Completed
Phase
Start date	December 2007
Completion date	January 2013

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03212742` - Phase I/IIa Study of Concomitant Radiotherapy With Olaparib and Temozolomide in Unresectable High Grade Gliomas Patients	Phase 1/Phase 2
Recruiting	`NCT06190782` - Local Therapy for Oligometastatic ESCC Patients Treated With PD-1 Inhibitor	Phase 3
Recruiting	`NCT06120127` - Postoperative Chemotherapy With/Without Radiotherapy and Immunotherapy for Colorectal Liver Metastases With High Risk of Locally Recurrence	Phase 2
Recruiting	`NCT05176002` - Camrelizumab in Combination With Radiotherapy for Neoadjuvant Esophageal Carcinoma.	Phase 1/Phase 2
Not yet recruiting	`NCT05909137` - Omitting Clinical Target Volume in Radical Treatment of Unresectable Stage III Non-small Cell Lung Cancer
Recruiting	`NCT02661152` - DAHANCA 30: A Randomized Non-inferiority Trial of Hypoxia-profile Guided Hypoxic Modification of Radiotherapy of HNSCC.	Phase 3
Withdrawn	`NCT02542137` - Abscopal Effect for Metastatic Small Cell Lung Cancer	Phase 2
Completed	`NCT01212731` - Skull Base and Low Grade Glioma Neurocognitive Magnetic Resonance Imaging (MRI) Study
Completed	`NCT01168479` - FLAME: Investigate the Benefit of a Focal Lesion Ablative Microboost in Prostate Cancer	Phase 3
Recruiting	`NCT03658343` - T2* MRI Analysis for Sarcoma	N/A
Completed	`NCT03280719` - Whole Breast + Lymph Node Irradiation: Prone Compared to Supine Position in 15 or 5 Fractions	N/A
Recruiting	`NCT05514327` - A Study of Ultra-fraction Radiotherapy Bridging CART in R/R DLBCL	N/A
Recruiting	`NCT05515796` - Multi-omics Sequencing in Neoadjuvant Immunotherapy of Gastrointestinal Tumors	Phase 2
Recruiting	`NCT04453826` - Concurrent and Adjuvant PD1 Treatment Combined With Chemo-radiotherapy for High-risk Nasopharyngeal Carcinoma	Phase 3
Recruiting	`NCT03370926` - FET-PET and Multiparametric MRI for High-grade Glioma Patients Undergoing Radiotherapy	N/A
Active, not recruiting	`NCT03870919` - Locoregional Treatment and Palbociclib in de Novo, Treatment Naive, Stage IV ER+, HER2- Breast Cancer Patients	N/A
Active, not recruiting	`NCT02428049` - Radiation Pneumonitis After SBRT for NSCLC
Recruiting	`NCT04923620` - Neoadjuvant Cetuximab + Chemotherapy Combined With Short-course Radiotherapy
Active, not recruiting	`NCT05371795` - Comparison on Radiotherapy Permanent Skin Marking With Lancets and an Electric Marking Device	N/A
Recruiting	`NCT03210428` - Quantitative MR Imaging in Locally Advanced Cervical Cancer